{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:50:56Z","timestamp":1792219856708,"version":"4.4.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02504","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T04:18:03Z","timestamp":1572409083000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using \u03b1\u03b2+ T-Cell Receptor and CD19+ Cell Depleted Grafts: High CD56dim\/CD56bright NK Cell Ratio Early Following Transplantation Is Associated With Lower Relapse Incidence and Better Outcome"],"prefix":"10.3389","volume":"10","author":[{"given":"Miguel A.","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josune","family":"Zubicaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorea","family":"Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Galvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Vicario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gonz\u00e1lez-Vicent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/sj.bmt.1705963","article-title":"Searching for alternative hematopoietic stem cell donors for pediatric patients","volume":"41","author":"Rocha","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/sj.leu.2402382","article-title":"Haploidentical \u201cmegadose\u201d CD34+ cell transplants for patients with acute leukemia","volume":"16","author":"Martelli","year":"2002","journal-title":"Leukemia."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/bmt.2015.86","article-title":"Haploidentical hematopoietic stem cell transplantation: state of art","volume":"50","author":"Reisner","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1053\/j.seminhematol.2016.07.001","article-title":"Haploidentical transplantation using \u201cex-vivo\u201d T-cell depletion","volume":"53","author":"Martelli","year":"2016","journal-title":"Seminars Hematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3324\/haematol.2009.021121","article-title":"Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B- cell depleted grafts in children","volume":"95","author":"Pfeiffer","year":"2010","journal-title":"Haematologica."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/bmt.2012.43","article-title":"Early evaluation of immune reconstitution following allogeneic CD3\/CD19-depleted grafts from alternative donors in childhood acute leukemia","volume":"47","author":"P\u00e9rez-Mart\u00ednez","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/bmt.2016.101","article-title":"Prognostic factors and outcomes for pediatric patients receiving an haploidentical related allogeneic transplantation using CD3\/CD19-depleted grafts","volume":"51","author":"Diaz","year":"2016","journal-title":"Bone marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/MPH.0b013e3181cf813c","article-title":"Graft manipulation and reduced-intensity conditioning for allogeneic hematopietic stem cell transplantation from mismatched unrelated and mismatched\/haploidentical related donors in pediatric leukemia patients","volume":"32","author":"Gonzalez-Vicent","year":"2010","journal-title":"J Pediatric Hematol Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcomes of children with acute leukemia given HLA haploidentical HSCT after \u03b1\u03b2 T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/bmt.2015.343","article-title":"TCR-alpha\/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia","volume":"51","author":"Maschan","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":"Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.leukres.2017.03.001","article-title":"Donor age matters in T-cell depleted haploidentical hematopoietic stem cell transplantation in pediatric patients: faster immune reconstitution using younger donors","volume":"57","author":"Gonz\u00e1lez-Vicent","year":"2017","journal-title":"Leukemia Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1046\/j.1365-2141.1997.8512479.x","article-title":"Allogeneic peripheral blood progenitor cell (PBPC) transpantation in children with haematological malignancies","volume":"96","author":"Diaz","year":"1997","journal-title":"Br J Haematol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.bbmt.2011.05.007","article-title":"Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD","volume":"17","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"B16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Am Stat."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/bmt.2009.359","article-title":"Regression modeling of competing risk using R: a in depth guide for clinicians","volume":"45","author":"Scrucca","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/CCO.0000000000000480","article-title":"Allogeneic hematopoietic stem-cell transplantation from haploidentical donor using \u2018ex-vivo' T-cell depletion in pediatric patients with hematological malignancies: state of the art review","volume":"30","author":"Gonzalez-Vicent","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1053\/j.seminoncol.2012.09.007","article-title":"New approaches to graft engineering for haploidentical bone marrow transplantation","volume":"39","author":"Handgretinger","year":"2012","journal-title":"Seminars Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1182\/blood-2014-03-565069","article-title":"KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL","volume":"124","author":"Oevermann","year":"2014","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1172\/JCI1268","article-title":"Supression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation","volume":"109","author":"Asai","year":"1998","journal-title":"J Clin Invest."},{"key":"B23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.smim.2006.03.002","article-title":"Surface NK receptors and their ligands on tumor cells","volume":"18","author":"Moretta","year":"2006","journal-title":"Seminars Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/bjh.12810","article-title":"Transplantation of CD3\/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia","volume":"165","author":"Lang","year":"2014","journal-title":"Br J Haematol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.bbmt.2019.02.025","article-title":"Thiotepa, Busulfan and Fludarabine conditioning regimen in T-cell repleted HLA-haploidentical hematopoietic stem cell transplantation","volume":"25","author":"Dulery","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3389\/fimmu.2018.01841","article-title":"Joint modeling of immune reconstitution post haploidentical stem cell transplantation in pediatric patients with acute leukemia comparing CD34+ selected to CD3\/CD19 depleted grafts in a retrospective multicenter study","volume":"9","author":"Salzmann-Manrique","year":"2018","journal-title":"Front Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1182\/blood-2017-05-780668","article-title":"NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications","volume":"131","author":"Russo","year":"2018","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1182\/bloodadvances.2017008631","article-title":"The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT","volume":"1","author":"Maggs","year":"2017","journal-title":"Blood Adv"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e13147","DOI":"10.1111\/ctr.13147","article-title":"Reconstitution of T and NK cells after haploidentical hematopoietic cell transplantation using \u03b1\u03b2 T cell-depleted grafts and the clinical implication of \u03b3\u03b4 T cells","volume":"32","author":"Park","year":"2018","journal-title":"Clin Transplant"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.febslet.2011.04.061","article-title":"Human NK receptors: from the molecules to the therapy of high risk leukemias","volume":"585","author":"Moretta","year":"2011","journal-title":"FEBS Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2141.2011.08823.x","article-title":"Use of NK cell activity in cure by transplant","volume":"155","author":"Leung","year":"2011","journal-title":"Br J Haematol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2013.00015","article-title":"Cellular and molecular basis of haploidentical stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells","volume":"4","author":"Locatelli","year":"2013","journal-title":"Front Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3389\/fimmu.2014.00439","article-title":"Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective","volume":"5","author":"Eguizabal","year":"2014","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.bbmt.2018.02.023","article-title":"Early immune reconstitution of NK and \u03b3\u03b4 T cells and its implication for the design of post-transplant immunotherapy","volume":"24","author":"de Witte","year":"2018","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02504\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T04:18:04Z","timestamp":1572409084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02504\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2019.02504"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02504","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"article-number":"2504"}}